Alnylam Pharmaceuticals, Inc. (ALNY) Posts Narrower than Expected Q1 Loss
Tweet Send to a FriendGet Alerts ALNY Hot Sheet
Price: $28.06 --0%
EPS Growth %: +40.0%
Financial Fact:
General and administrative: 6.27M
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: +40.0%
Financial Fact:
General and administrative: 6.27M
Today's EPS Names:
ANF, DXLG, FL, More
Trade ALNY Now!
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q1 EPS of ($0.25), $0.11 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $19.57 million.
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess Health Care Conference
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
